Inhibitors of MEK Kinase
Copyright © Targeted News Service 2024
2024-10-22
ALEXANDRIA, Virginia, Oct. 22 -- KINNATE BIOPHARMA INC., San Diego, California has been assigned a patent (No. US 12122800 B2, initially filed June 15, 2023) developed by three inventors Toufike Kanouni, Palm Beach Gardens, Florida; Robert S. Kania, Del Mar, California; and Jason M. Cox, Rancho Santa Fe, California, for "Inhibitors of MEK kinase." . . .